| AA | Ascorbic Acid |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| AQP4 | Aquaporin-4 |
| BBB | Blood–Brain Barrier |
| BDNF | Brain-Derived Neurotrophic Factor |
| CBF | Cerebral Blood Flow |
| CBV | Cerebral Blood Volume |
| CCI | Controlled Cortical Impact |
| COX | Cyclooxygenase |
| CSF | Cerebro-Spinal Fluid |
| CT | Computed Tomography |
| CTE | Chronic Traumatic Encephalopathy |
| DHA | Docosohexaenoic Acid |
| DHE | Dihydroethidium Staining |
| DRP1 | Dynamin-Related Protein 1 |
| EEG | Electroencephalography |
| eNOS | Endothelial Nitric Oxide Synthase |
| EPA | Eicosapentaenoic Acid |
| ETC | Electron Transfer Chain |
| FIS1 | Fission Protein 1, mitochondrial |
| FJB/C | Fluoro Jade B or C staining |
| FST | Forced Swimming Test |
| FPI | Fluid Percussion Injury |
| GAP-43 | Growth-Associated Protein-43 |
| GCS | Glasgow Coma Scale |
| GFAP | Glial Fibrillary Acidic Protein |
| GPx | Glutathione Peroxidases |
| GSH | Reduced Glutathione |
| GSK-3β | Glycogen Synthase Kinase 3 Beta |
| GSNA | Greater Splanchnic Nerve Activity |
| GSNO | Nitrosoglutathione |
| GR | GSH Reductase |
| GSSG | Oxidized Glutathione |
| Hb | Haemoglobin |
| H&E | Hematoxylin and Eosin staining rotocol |
| ICH | Immunohistochemistry |
| ICP | Intracranial Pressure |
| IL | Interleukin |
| iNOS | Inducible Nitric Oxide Synthase |
| i.m. | Intramuscular |
| i.v. | Intravenous |
| lncRNA Neat1 | Long noncoding RNA nuclear enriched abundant transcript 1 |
| MDA | Malondialdehyde |
| MFN1 or 2 | Mitofusin 1 or 2 |
| MINO | Minocycline |
| mNSS | Modified Neurological Severity Score |
| mTBI | Mild Traumatic Brain Injury |
| MWM | Morris Water Maze |
| NAC | N-Acetylcystein |
| NFL | Neurofilament Light |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NICUs | Neurosurgical Intensive Care Units |
| NKCC | Sodium–potassium–chloride cotransporter |
| NMDA | N-Methyl-D-Aspartate |
| nNOS | Neuronal Nitric Oxide Synthase |
| NO | Nitric oxide |
| NOR | Novel Object Recognition |
| NOS | Nitric Oxide Synthases |
| NOX | NADPH Oxidase |
| NP | Neuropsychological |
| Nrf2-ARE | Nuclear factor E2-related factor 2 Antioxidant Response Elements |
| NSS | Neurological Soft Signs |
| OPA1 | Optic dominant Atrophy 1 |
| OXPHOS | Oxidative Phosphorylation |
| PARK2 | Parkin |
| PAT | Passive Avoidance Task |
| PEG | Polyethylene Glycol |
| PINK1 | mitochondrial serine/threonine-protein kinase 1 |
| PTSD | Posttraumatic Stress Disorder |
| PUFA | Polyunsaturated Fatty Acids |
| RNS | Reactive Nitrogen Species |
| ROS | Reactive Oxygen Species |
| SIS | Second Impact Syndrome |
| SOD | Superoxide Dismutase |
| SVCT1 or 2 | Sodium dependent vitamin C transporter 1 or 2 |
| SYP | Synaptophysin |
| TAC | Total Antioxidant Capacity |
| TBARS | Thiobarbituric Acid Reactive Substance |
| TBI | Traumatic Brain Injury |
| TEM | Transmission Electron Microscopy |
| TST | Tail Suspension Test |
| TUNEL | Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling assay |
| UCH-L1 | Ubiquitin Carboxy-terminal Hydrolase-L1 |
| VCS | Veterinary Coma Scale |
| VR | Virtual Reality |
| WB | Western Blot |
| WD | Weight Drop |
| XO | Xanthine Oxidase |